Both in Pharmaceuticals
Liquidia vs Dianthus Therapeutics
Over the past year LQDA returned +97.5% and DNTH returned +144.5%; their daily moves had a correlation of 0.14.
LQDA +97.5% DNTH +144.5%Growth of $1, one year, split-adjusted
| Metric | LQDA | DNTH |
|---|---|---|
| Price | $45.72 | $82.31 |
| Market cap | $4.09B | $4.60B |
| Today | +0.62% | +3.51% |
| 1 month | −35.3% | −5.6% |
| 6 months | +19.8% | −1.4% |
| Year to date | +32.6% | +99.7% |
| 1 year | +100.9% | +145.6% |
| Revenue growth (YoY) | +1842.7% | +294.3% |
| Gross margin | 93.3% | 100.0% |
| Net margin | 43.5% | −6598.6% |
| P/E (TTM) | 29.5× | — |
| Price / sales | 9.1× | 2,418.0× |
| Net cash | $108.1M | $886.8M |
| Dividend yield | — | — |
| Volatility (60d) | 189.4% | 39.2% |
| Short % of float | 26.2% | 18.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).